TIGIT and influenza: While percentages of TIGIT+ Treg specific for C. albicans and K. pneumoniae were comparable to those specific for S. aureus (Figure 5E), those specific for SARS-CoV-2 spike protein or for an inactivated tetravalent influenza vaccine were significantly lower (Figure 5F).